Kakala - generally speaking what your saying is correct. Many Aust biotechs (with significantly smaller market caps) have listed on NASDAQ with the hype that the SP will sky rocket due to "savvy US investors"...only to be greeted with huge dissappointments on listing.
IMO - our CEO( Mr De-Risk) is all over the pros and cons of a NASDAQ listing. The fact that MSB have not as yet listed on the US market tells me how sharp and measured our CEO is.
Agree Vinny - could be a significant event.
ALL US/UK/EURO Biotechs and Pharmas(of note) have either a NYSE or NASDAQ listing. They are ALL well supported by Global fund managers. It would make sense that MSB join them when the stage is set.
At present just happy the way things are developing(excluding SP)...updates cannot be too far away.
GLTAH and DYOR.
Kakala - generally speaking what your saying is correct. Many...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |